{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:36:55Z","timestamp":1794361015426,"version":"4.9.0"},"publisher-location":"Totowa, NJ","reference-count":20,"publisher":"Humana Press","isbn-type":[{"value":"9781934115824","type":"print"},{"value":"9781597455640","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008]]},"DOI":"10.1007\/978-1-59745-564-0_1","type":"book-chapter","created":{"date-parts":[[2009,1,5]],"date-time":"2009-01-05T12:29:02Z","timestamp":1231158542000},"page":"3-7","source":"Crossref","is-referenced-by-count":0,"title":["Staging in Multiple Myeloma"],"prefix":"10.1007","author":[{"given":"Leonard T.","family":"Heffner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"6","key":"1_CR1_1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0002-9343(67)90074-5","volume":"42","author":"P.P. Carbone","year":"1967","unstructured":"Carbone, P.P., L.E. Kellerhouse,and E.A. Gehan, Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Am J Med, 1967. 42(6): pp. 937\u201348.","journal-title":"Am J Med"},{"issue":"552","key":"1_CR2_1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/pgmj.47.552.635","volume":"47","author":"A.A Dawson","year":"1971","unstructured":"Dawson, A. A and D. Ogston, Factors influencing the prognosis in myelomatosis Postgrad Med J, 1971. 47(552): pp. 635\u20138.","journal-title":"Postgrad Med J"},{"issue":"1","key":"1_CR3_1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2141.1973.tb05733.x","volume":"24","author":"Report on the first myelomatosis trial","year":"1973","unstructured":"Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance. Br J Haematol, 1973. 24(1): pp. 123\u201339.","journal-title":"Br J Haematol"},{"key":"1_CR4_1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1126\/science.148.3668.376","volume":"148","author":"D.E. Bergsagel","year":"1965","unstructured":"Bergsagel, D.E., P.J. Migliore, and K.M. Griffith, Myeloma proteins and the clinical response to melphalan therapy. Science, 1965. 148: pp. 376\u20137.","journal-title":"Science"},{"key":"1_CR5_1","doi-asserted-by":"crossref","unstructured":"Correlation of abnormal immunoglobulin with clinical features of myeloma. Arch Intern Med, 1975. 135(1): pp. 46\u201352.","DOI":"10.1001\/archinte.1975.00330010048007"},{"issue":"4","key":"1_CR6_1","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO;2-I","volume":"36","author":"R. Alexanian","year":"1975","unstructured":"Alexanian, R., et al., Prognostic factors in multiple myeloma. Cancer, 1975. 36(4): pp. 1192\u2013201.","journal-title":"Cancer"},{"issue":"3","key":"1_CR7_1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"B.G. Durie","year":"1975","unstructured":"Durie, B.G. and S.E. Salmon, A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 1975. 36(3): pp. 842\u201354.","journal-title":"Cancer"},{"issue":"3","key":"1_CR8_1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2141.1983.tb02158.x","volume":"55","author":"R. Bataille","year":"1983","unstructured":"Bataille, R., B.G. Durie, and J. Grenier, Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging. Br J Haematol, 1983. 55(3): pp. 439\u201347.","journal-title":"Br J Haematol"},{"issue":"3","key":"1_CR9_1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1600-0609.1991.tb01273.x","volume":"46","author":"P.G. Gobbi","year":"1991","unstructured":"Gobbi, P.G., et al., A plea to overcome the concept of staging and related inadequacy in multiple myeloma. Eur J Haematol, 1991. 46(3): pp. 177\u201381.","journal-title":"Eur J Haematol"},{"key":"1_CR10_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0609.1989.tb01501.x","volume":"51","author":"G. Merlini","year":"1989","unstructured":"Merlini, G., P.G. Gobbi, and E. Ascari, The Merlini, Waldenstrom, Jayakar staging system revisited. Eur J Haematol Suppl, 1989. 51: pp. 105\u201310.","journal-title":"Eur J Haematol Suppl"},{"issue":"1","key":"1_CR11_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1200\/JCO.1986.4.1.80","volume":"4","author":"R. Bataille","year":"1986","unstructured":"Bataille, R., et al., Prognostic factors and staging in multiple myeloma: A reap-praisal. J Clin Oncol, 1986. 4(1): pp. 80\u20137.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1_CR12_1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2141.2003.04456.x","volume":"122","author":"J.L. Jacobson","year":"2003","unstructured":"Jacobson, J.L., et al., A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience. Br J Haematol, 2003. 122(3): pp. 441\u201350.","journal-title":"Br J Haematol"},{"issue":"15","key":"1_CR13_1","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"P.R. Greipp","year":"2005","unstructured":"Greipp, P.R., et al., International Staging System for multiple myeloma. J Clin Oncol, 2005. 23(15): pp 3412\u201320","journal-title":"J Clin Oncol"},{"issue":"2","key":"1_CR14_1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bmt.1704728","volume":"35","author":"M. Krejci","year":"2005","unstructured":"Krejci, M., et al., Prognostic factors for survival after autologous transplantation: A single centre experience in 133 multiple myeloma patients. Bone Marrow Transplant, 2005. 35(2): pp. 159\u201364.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"1_CR15_1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","volume":"106","author":"P.L. Bergsagel","year":"2005","unstructured":"Bergsagel, P.L., et al., Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma. Blood, 2005. 106(1): pp. 296\u2013303.","journal-title":"Blood"},{"issue":"26","key":"1_CR16_1","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1200\/JCO.2005.05.021","volume":"23","author":"P.L. Bergsagel","year":"2005","unstructured":"Bergsagel, P.L. and W.M. Kuehl, Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol, 2005. 23(26): pp. 6333\u20138.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1_CR17_1","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","volume":"42","author":"B.G. Durie","year":"2006","unstructured":"Durie, B.G., The role of anatomic and functional staging in myeloma: Description of Durie\/Salmon plus staging system. Eur J Cancer, 2006. 42(11): pp. 1539\u201343.","journal-title":"Eur J Cancer"},{"issue":"9","key":"1_CR18_1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","volume":"25","author":"R. Walker","year":"2007","unstructured":"Walker, R., et al., Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications. J Clin Oncol, 2007. 25(9): pp. 1121\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1_CR19_1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00330-005-0055-7","volume":"16","author":"N. Ghanem","year":"2006","unstructured":"Ghanem, N., et al., Whole\u2013body MRI in the detection of bone marrow infitteration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol, 2006. 16(5): pp. 1005\u201314.","journal-title":"Eur Radiol"},{"issue":"1","key":"1_CR20_1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3324\/haematol.10554","volume":"92","author":"E. Zamagni","year":"2007","unstructured":"Zamagni, E., et al., A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica, 2007. 92(1): pp. 50\u20135.","journal-title":"Haematologica"}],"container-title":["Myeloma Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-59745-564-0_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T10:46:31Z","timestamp":1709894791000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-59745-564-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"ISBN":["9781934115824","9781597455640"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-59745-564-0_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-59745-564-0","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2008]]}}}